Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03493828 · ClinicalTrials.gov registry record · Phase 3
Efficacy of TAP Block in Cesarean Section Patients
A Phase 3 study of Pain Control, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03493828: Completed Phase 3 study of Pain Control, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
NCT03493828 is a Phase 3 study of Pain Control that has completed, run by New York Presbyterian Brooklyn Methodist Hospital. The registered enrollment target is 60 participants, above the 32-participant average among 3 other Pain Control trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03493828, a Phase 3 study of Pain Control, has completed, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
TAP Block done with 2 different concentrations of bupivacaine and placebo
Primary Outcome
The total the number of Patient Controlled Analgesia (PCA) boluses used by the patients postoperatively within 24 hours
Conditions Studied
Interventions
- PROCEDURE TAP block using Bupivacaine 0.5%
- PROCEDURE TAP block using Bupivacaine 0.25%
- PROCEDURE TAP block using Normal Saline
Study Locations (1)
New York
- New York Methodist Hospital - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
What the finished NCT03493828 record still lists
NCT03493828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 32-participant average among 3 other Pain Control trials with a reported enrollment target (88% higher).
The record links to 1 condition, with Pain Control appearing as the primary indexed condition, and to 3 interventions - of which TAP block using Bupivacaine 0.5% is the first listed.
NCT03493828 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03493828 about?
NCT03493828 is a clinical study titled "Efficacy of TAP Block in Cesarean Section Patients". TAP Block done with 2 different concentrations of bupivacaine and placebo
What is the current status of trial NCT03493828?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2013-06. Estimated completion is 2013-12.
What conditions does trial NCT03493828 study?
This clinical trial studies the following conditions: Pain Control.
What interventions are being tested in trial NCT03493828?
The interventions under investigation include: TAP block using Bupivacaine 0.5% (PROCEDURE), TAP block using Bupivacaine 0.25% (PROCEDURE), TAP block using Normal Saline (PROCEDURE).
Who is sponsoring clinical trial NCT03493828?
This trial is sponsored by New York Presbyterian Brooklyn Methodist Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03493828 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia